title: Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
abstract: Among the extraintestinal manifestations of inflammatory bowel disease (IBD), pyoderma gangrenosum (PG) often poses a therapeutic challenge. We describe two cases of PG associated with inflammatory bowel disease, who responded to treatment with Infliximab.
authors: Servicio de Reumatología, Hospital de Jerez de Frontera, Cádiz, Spain. maricarmen.carrasco@yahoo.es
authors: Carmen
authors: C
authors: Carrasco Cubero
authors: M Mar
authors: MM
authors: Ruiz Tudela
authors: José Javier
authors: JJ
authors: Salaberri Maestrojuan
authors: José Javier
authors: JJ
authors: Pérez Venegas
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D015796:HLA-B27 Antigen / Q000032:analysis; D006801:Humans; D000069285:Infliximab; D007871:Leg Ulcer / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000209:etiology*; D012003:Rectal Fistula / Q000209:etiology; D016038:Skin Transplantation; D012883:Skin Ulcer / Q000188:drug therapy / Q000209:etiology; D013167:Spondylitis, Ankylosing / Q000150:complications
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015796:HLA-B27 Antigen; D019804:Mesalamine; D000069285:Infliximab